Results 21 to 30 of about 76 (56)

Abstract B10: HGF enhances tumor cell survival in canertinib-treated medulloblastoma cell lines

open access: yes, 2014
Medulloblastoma is the most common malignant pediatric brain tumor. Unfortunately, conventional therapies have led to long-term side effects in the majority of survivors.
Eelco W. Hoving   +6 more
core   +1 more source

Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes. [PDF]

open access: yesAm J Med Genet A, 2021
Pirozzi F   +12 more
europepmc   +1 more source

Mapping the MicroRNA Landscape in Central Nervous System Malignancies: Functional Role and Clinical Relevance [PDF]

open access: yes
Glioblastoma (GB) is the most aggressive and lethal brain tumour found in adults and is characterised by poor prognosis and limited treatment options.
Mustafov, Denis
core  

miRNA-10b is highly expressed in medulloblastoma cells.

open access: yes
Total RNA was extracted from medulloblastoma cells and subjected to RT-PCR analysis. (A) Oncomir microarray using quantitative RT-PCR in DAOY cells compared to normal cerebellum and FirstChoice® Human Brain Reference RNA. MicroRNA heat map profile.
Rekha Pal (131513)   +1 more
core   +2 more sources

Recent Advances in Understanding the Role of Autophagy in Paediatric Brain Tumours. [PDF]

open access: yesDiagnostics (Basel), 2021
Gatto F   +5 more
europepmc   +1 more source

Knockdown of BCL2 by specific siRNA induces significant inhibition of miRNA-10b expression.

open access: yes
DAOY, UW228, D283 384 Med, 425 Med, UW426 and UW402 medulloblastoma cells were collected and lysed, and cell lysates were fractionated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto PVDF membranes to ...
Rekha Pal (131513)   +1 more
core   +2 more sources

Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma. [PDF]

open access: yesFront Cell Dev Biol, 2022
Marabitti V   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy